Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation

Carcinogenesis

Volumn 34, Issue 8, 2013, Pages 1918-1928

  Yoon, Mi Jin ^a   Kang, You Jung ^a   Kim, In Young ^a   Kim, Eun Hee ^a   Lee, Ju Ahn ^a   Lim, Jun Hee ^a   Kwon, Taeg Kyu ^b   Choi, Kyeong Sook ^a  

^a Ajou University School of Medicine   (South Korea)

^b Keimyung University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FLICE INHIBITORY PROTEIN; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; LASALOCID; MONENSIN; NARASIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NIGERICIN; PROTEASOME; PROTEIN BCL 2; PROTEIN BCL XL; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; SALINOMYCIN; SYNAPTOTAGMIN I; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; ASTROCYTE; CANCER RESISTANCE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SENSITIZATION;

EID: 84881531214     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt137     Document Type: Article

References (49)

1. Ashkenazi, A. et al. (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J. Clin. Invest., 104, 155-162.
2. Hawkins, C.J. (2004) TRAIL and malignant glioma. Vitam. Horm., 67, 427-452.
3. Yoshida, T., et al. (2009) Repeated treatment with subtoxic doses of TRAIL induces resistance to apoptosis through its death receptors in MDA-MB-231 breast cancer cells. Mol. Cancer Res., 7, 1835-1844.
4. Lima, F.R., et al. (2012) Glioblastoma: therapeutic challenges, what lies ahead. Biochim. Biophys. Acta, 1826, 338-349.
5. Knight, M.J., et al. (2001) Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells. Oncogene, 20, 5789-5798.
6. Butaye, P., et al. (2003) Antimicrobial growth promoters used in animal feed: effects of less well known antibiotics on gram-positive bacteria. Clin. Microbiol. Rev., 16, 175-188.
7. Pressman, B.C. (1976) Biological applications of ionophores. Annu. Rev. Biochem., 45, 501-530.
8. Lutz, W.K., et al. (1971) Crystal structure of the antibiotic monensin similarities and differences between free acid and metal complex. Helv. Chim. Acta, 54, 1103-1108.
9. Pressman, B.C., et al. (1977) Biological applications and evolutionary origins of ionophores. Adv. Exp. Med. Biol., 84, 285-300.
10. Galitzer, S.J., et al. (1982) Preliminary studies on lasalocid toxicosis in cattle. Vet. Hum. Toxicol., 24, 406-409.
11. Miraglia, E., et al. (2005) Na+/H+ exchanger activity is increased in doxorubicin- resistant human colon cancer cells and its modulation modifies the sensitivity of the cells to doxorubicin. Int. J. Cancer, 115, 924-929.
12. Fuchs, D., et al. (2010) Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells. Biochem. Biophys. Res. Commun., 394, 1098-1104.
13. Riccioni, R., et al. (2010) The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. Blood Cells. Mol. Dis., 45, 86-92.
14. Gupta, P.B., et al. (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell, 138, 645-659.
15. Huczynski, A. (2012) Polyether ionophores-promising bioactive molecules for cancer therapy. Bioorg. Med. Chem. Lett., 22, 7002-7010.
16. Kim,.U., et al. (1986) Neuroimmunology of gangliosides in human neurons and glial cells in culture. J. Neurosci. Res., 15, 303-321.
17. Chou, T.C., et al. (1984) Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul., 22, 27-55.
18. Cleary, I., et al. (1997) The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Biochem. Pharmacol., 53, 1493-1502.
19. Grinde, B. (1983) Effect of carboxylic ionophores on lysosomal protein degradation in rat hepatocytes. Exp. Cell Res., 149, 27-35.
20. Boya., et al. (2005) Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol., 25, 1025-1040.
21. Yoshimori, T., et al. (1991) Bafilomycin A1, a specific inhibitor of vacuolartype H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem., 266, 17707-17712.
22. Seglen, P.O., et al. (1980) Effects of lysosomotropic monoamines, diamines, amino alcohols, and other amino compounds on protein degradation and protein synthesis in isolated rat hepatocytes. Mol. Pharmacol., 18, 468-475.
23. Ichimura, Y., et al. (2008) Selective turnover of p62/A170/SQSTM1 by autophagy. Autophagy, 4, 1063-1066.
24. Kirkin, V., et al. (2009) A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol. Cell, 33, 505-516.
25. Uchiyama, Y. (2001) Autophagic cell death and its execution by lysosomal cathepsins. Arch. Histol. Cytol., 64, 233-246.
26. Dinter., et al. (1998) Golgi-disturbing agents. Histochem. Cell Biol., 109, 571-590.
27. Oku, M., et al. (2011) Novel cis-acting element GASE regulates transcriptional induction by the Golgi stress response. Cell Struct. Funct., 36, 1-12.
28. Azfer, A., et al. (2006) Activation of endoplasmic reticulum stress response during the development of ischemic heart disease. Am. J. Physiol. Heart Circ. Physiol., 291, H1411-H1420.
29. LeBlanc, H.N., et al. (2003) Apo2L/TRAIL and its death and decoy receptors. Cell Death Differ., 10, 66-75.
30. Chen, L.H., et al. (2007) Thapsigargin sensitizes human melanoma cells to TRAIL-induced apoptosis by up-regulation of TRAIL-R2 through the unfolded protein response. Carcinogenesis, 28, 2328-2336.
31. Shiraishi, T., et al. (2005) Tunicamycin enhances tumor necrosis factorrelated apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Cancer Res., 65, 6364-6370.
32. Fukazawa, T., et al. (2001) Accelerated degradation of cellular FLIP protein through the ubiquitin-proteasome pathway in p53-mediated apoptosis of human cancer cells. Oncogene, 20, 5225-5231.
33. Pressman, B.C., et al. (1982) Pharmacology and toxicology of the monovalent carboxylic ionophores. Annu. Rev. Pharmacol. Toxicol., 22, 465-490.
34. Vhapman, H.D., et al. (2010) Forty years of monensin for the control of poultry. Poult. Sci., 89, 1788-1801.
35. Ketola, K., et al. (2012) Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress. Br. J. Cancer, 106, 99-106.
36. Lu, D., et al. (2011) Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proc. Natl Acad. Sci. USA, 108, 13253-13257.
37. Mashima, T., et al. (2010) Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormonerefractory prostate cancer cell growth. Mol. Pharmacol., 78, 846-854.
38. Borrel, M.N., et al. (1994) Analysis of multidrug transporter in living cells. Inhibition of P-glycoprotein-mediated efflux of anthracyclines by ionophores. Met. Based. Drugs, 1, 175-182.
39. Ghiaur, G., et al. (2012) Concise review: cancer stem cells and minimal residual disease. Stem Cells, 30, 89-93.
40. Haugejorden, S.M., et al. (1991) Analysis of the retention signals of two resident luminal endoplasmic reticulum proteins by in vitro mutagenesis. J. Biol. Chem., 266, 6015-6018.
41. Oyadomari, S., et al. (2004) Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ., 11, 381-389.
42. Rao, R.V., et al. (2004) Coupling endoplasmic reticulum stress to the cell death program. Cell Death Differ., 11, 372-380.
43. Son, Y.G., et al. (2007) Silibinin sensitizes human glioma cells to TRAILmediated apoptosis via DR5 up-regulation and down-regulation of c-FLIP and survivin. Cancer Res., 67, 8274-8284.
44. Kim, E.H., et al. (2008) Arsenic trioxide sensitizes human glioma cells, but not normal astrocytes, to TRAIL-induced apoptosis via CCAAT/enhancerbinding protein homologous protein-dependent DR5 up-regulation. Cancer Res., 68, 266-275.
45. Tartakoff, A.M. (1983) Perturbation of the structure and function of the Golgi complex by monovalent carboxylic ionophores. Methods Enzymol., 98, 47-59.
46. Klausner. D., et al. (1992) Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol., 116, 1071-1080.
47. Kwok, S.C., et al. (2008) Brefeldin A activates CHOP promoter at the AARE, ERSE and AP-1 elements. Mol. Cell. Biochem., 319, 203-208.
48. Irmler, M., et al. (1997) Inhibition of death receptor signals by cellular FLIP. Nature, 388, 190-195.
49. Matta, H., et al. (2002) Role of MRIT/cFLIP in protection against chemotherapy- induced apoptosis. Cancer Biol. Ther., 1, 652-660.